Effects of donepezil on verbal memory after semantic processing in healthy older adults

Cognitive and Behavioral Neurology

Volumn 21, Issue 2, 2008, Pages 57-64

  Fitzgerald, David B ^a,b,k   Crucian, Gregory P ^c   Mielke, Jeannine B ^d   Shenal, Brian V ^e   Burks, David ^a,f   Womack, Kyle B ^g   Ghacibeh, Georges ^h   Drago, Valeria ^a,i   Foster, Paul S ^a,j   Valenstein, Edward ^a   Heilman, Kenneth M ^a,f  

^a UNIVERSITY OF FLORIDA   (United States)

^b Brain Rehabilitation Research Center   (United States)

^c Malcom Randall VAMC   (United States)

^d Private Practice   (United States)

^e UNIVERSITY OF CANTERBURY   (New Zealand)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h Private Practice   (United States)

ⁱ OASI RESEARCH INSTITUTE IRCCS   (Italy)

^j MIDDLE TENNESSEE STATE UNIVERSITY   (United States)

^k UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

more..

Author keywords

Acetylcholinesterase inhibitor; Aging; Donepezil; Memory; Semantic processing; Superficial processing

Indexed keywords

DONEPEZIL; HYOSCYAMINE; PLACEBO; CHOLINESTERASE INHIBITOR; INDAN DERIVATIVE; NOOTROPIC AGENT; PIPERIDINE DERIVATIVE;

AGED; ARTICLE; CLINICAL TRIAL; CONSONANT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFECT; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; HEART ATRIUM FIBRILLATION; HUMAN; LANGUAGE ABILITY; LEG CRAMP; MAINTENANCE DRUG DOSE; MALE; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEMANTIC MEMORY; TASK PERFORMANCE; TREATMENT DURATION; TREATMENT OUTCOME; VERBAL BEHAVIOR; VERBAL MEMORY; WORD RECOGNITION; ALZHEIMER DISEASE; ATTENTION; COMPREHENSION; DOSE RESPONSE; LEARNING; LONG TERM MEMORY; PATTERN RECOGNITION; PSYCHOLOGICAL ASPECT; RECALL; SEMANTICS; SHORT TERM MEMORY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATTENTION; CHOLINESTERASE INHIBITORS; COMPREHENSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INDANS; MALE; MEMORY, SHORT-TERM; MENTAL RECALL; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; PATTERN RECOGNITION, VISUAL; PIPERIDINES; RETENTION (PSYCHOLOGY); SEMANTICS; SERIAL LEARNING; VERBAL LEARNING;

EID: 49849105466     PISSN: 15433633     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNN.0b013e3181799df1     Document Type: Article

References (31)

1. Gabrieli J. Memory systems analyses of mnemonic disorders in aging and age-related diseases. PNAS. 1996;93:13534-13540.
2. Schliebs R, Arendt T. The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J Neural Transm. 2006;113:1625-1644.
3. Tresselt ME, Mayzner MS. A study of incidental learning. J Psychol. 1960;50:339-347.
4. Daselaar SM, Veltman DJ, Rombouts SARB, et al. Deep processing activates the medial temporal lobe in young but not old adults. Neurobiol Aging2003;24:1005-1011.
5. Logan JM, Sanders AL, Snyder AZ, et al. Under-recruitment and nonselective recruitment: dissociable neural mechanisms associated with aging. Neuron. 2002;33:827-840.
6. Yesavage JA, Mumenthaler MS, Taylor JL, et al. Donepezil and flight simulator performance: effects on retention of complex skills. Neurology. 2002;59:123-125.
7. Benton AL, Hamsher KD. Multilingual Aphasia Examination. Iowa City: University of Iowa; 1989.
8. Delis DC, Kramer JH, Kaplan E, et al. California Verbal LearningTest. San Antonio, TX: Psychological Corp; 1987.
9. Folstein MF, Folstein SE, McHugh PR. ''Mini-mental state.'' A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
10. Nelson HE. National Adult Reading Test (NART) Test Manual. Windsor: NFER-Nelson Publishing Co; 1982.
11. Kaplan EF, Goodglass H, Weintraub S. Boston Naming Test. Philadelphia: Lea and Febiger; 1983.
12. Yesavage JA, Brink TL. Development and validation of a Geriatric Depression Screening Scale: a preliminary report. J Psychiatr Res. 1983;17:37-49.
13. Battig WF, Montague WE. Category nouns for verbal items in 56 categories: a replication and extension of the Connecticut category norms. J Exp Psychol. 1969;80:1-46.
14. Francis WN, Kucera H. Frequency Analysis of English Usage: Lexicon and Grammar. Boston: Houghton Mifflin; 1982.
15. Toglia MP, Battig WF. Handbook of Semantic Word Norms. Hillsdale, NJ: Lawrence Erlbaum Associates; 1978.
16. Craik FIM, Lockhart RS. Levels of processing: a framework for memory research. J Verbal Learn Verbal Behav.1972;11: 671-684.
17. Brown AS, Mitchell DB. A reevaluation of semantic versus non- semantic processing in implicit memory. Mem Cogn.1994;22: 533-541.
18. Goodglass H, Kaplan E. The Assessment of Aphasia and Related Disorders.Philadelphia: Lea and Febiger; 1972.
19. Lowry R. Concepts & Applications of Inferential Statistics http://faculty.vassar.edu/lowry/webtext.html [online]. Available at: http://faculty.vassar.edu/lowry/webtext.html. Accessed August 20, 2007.
20. Pratt RD, Perdomo CA, Surick FW, et al. Donepezil: tolerability and safety in Alzheimer's disease. Int J Clin Pract. 2002;56: 710-717.
21. Beglinger LJ, Tangphao-Daniels O, Kareken DA, et al. Neuropsychological test performance in healthy elderly volunteers before and after donepezil administration. J Clin Psychopharmacol. 2005;25: 159-165.
22. Mihara M, Ohnishi A, Tomono Y, et al. Pharmacokinetics of E2020, a new compound for Alzheimer's disease in healthy male volunteers. Int J Clin Pharmacol Ther Toxicol. 1993;31: 223-229.
23. Barnes CA, Meltzer J, Houston F, et al. Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors. Neuroscience. 2000;99:17-23.
24. Gron G, Kirstein M, Thielscher A, et al. Cholinergic enhancement of episodic memory in healthy young adults. Psychopharmacology (Berlin).2005;182:170-179.
25. Drachman DA, Leavitt J. Human memory and the cholinergic system. Arch Neurol. 1974;30:113-121.
26. Drachman DA, Shakian BJ. Memory and cognitive function in the elderly. Arch Neurol. 1980;37:674-675.
27. Freo U, Ricciardi E, Pietrini P, et al. Pharmacological modulation of prefrontal cortical activity during a working memory task in young and older humans: a PET study with physostigmine. Am J Psychiatry. 2005;162:2061-2070.
28. Davis KL, Mohs RC, Tinklenberg JR, et al. Physostigmine: improvement of long term memory processes in normal humans. Science.1978;201:272-274.
29. Ohnishi A, Mihara M, Kamakura H, et al. Comparison of the pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy young and elderly subjects. J Clin Pharmacol.1993;33:1086-1091.
30. Imbibo BP. Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease. CNS Drugs. 2001;15: 375-390.
31. Doody RS, Geldmacher DS, Gordon B, et al. Open-label, multi- center, Phase 3 Extension Study of the safety and efficacy of donepezil in patients with Alzheimer disease. Arch Neurol. 2001;58: 427-433.